Related Experiment Videos
CD34-positive cell selection by immunomagnetic beads and chymopapain
F Silvestri1, S Banavali, M Yin
1University of Cincinnati Medical Center, OH.
Haematologica
|July 1, 1992
Summary
Researchers developed a method to isolate CD34+ progenitor cells from bone marrow and peripheral blood. This technique effectively separates clonogenic cells, crucial for leukemia research and treatment.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- CD34 antigen is expressed on pluripotent hematopoietic stem cells and clonogenic cells in acute nonlymphocytic leukemia (ANLL) and chronic myeloid leukemia (CML).
- Isolation of these CD34+ cells is critical for both experimental research and clinical applications in hematologic malignancies.
Purpose of the Study:
- To develop and evaluate a method for the efficient isolation of CD34+ progenitor cells.
- To assess the purity of isolated CD34+ cell fractions and the viability of clonogenic cells post-isolation.
Main Methods:
- Utilized MY10 antibody, sheep anti-mouse immunomagnetic beads, and chymopapain for CD34+ cell isolation from bone marrow and peripheral blood samples.
- Employed indirect immunofluorescence and semisolid culture assays to determine the percentage of CD34+ and clonogenic cells.
Main Results:
- Achieved a significant enrichment of CD34+ cells, increasing from 24.3% in unseparated samples to 85.0% in the isolated CD34-positive fraction.
- Demonstrated that the majority of clonogenic cells were successfully isolated in the CD34-positive fraction, with minimal presence in the CD34-negative fraction.
- Confirmed that chymopapain treatment was non-toxic to the clonogenic cells, preserving their viability.
Conclusions:
- Positive immunoselection using MY10 antibody, immunomagnetic beads, and chymopapain is an effective method for isolating highly pure CD34+ progenitors.
- This method is applicable to bone marrow and peripheral blood from both normal individuals and patients with myeloid leukemias.
- The isolation technique preserves the integrity and clonogenic potential of hematopoietic progenitor cells.